Etoposide. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Combination Chemotherapy of Cancer

Overview

Journal Drugs

Specialty Pharmacology

Date 1990 Mar 1

PMID 2184009

Citations 42

Authors

J M Henwood

R N Brogden

Affiliations

Soon will be listed here.

Citing Articles

A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors.

Wang X, Yao C, Quan L, Zhou J Front Pharmacol. 2025; 16:1472945.

PMID: 39981182 PMC: 11841460. DOI: 10.3389/fphar.2025.1472945.

Rapid Detection of the Anti-Tumor Drug Etoposide in Biological Samples by Using a Nanoporous-Gold-Based Electrochemical Sensor.

Yu H, Hu M, Wang X, Wang X, Xun L, Liu H Molecules. 2024; 29(5).

PMID: 38474572 PMC: 10933961. DOI: 10.3390/molecules29051060.

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?.

Cui Z, Cheng F, Wang L, Zou F, Pan R, Tian Y Front Pharmacol. 2023; 14:1259908.

PMID: 37954852 PMC: 10637489. DOI: 10.3389/fphar.2023.1259908.

The protective effect of taurine, piracetam and vinpocetine on etoposide-induced inflammation and brain injury in the serum of female albino rats.

Mohammed A, Al-Hassani A, Alrawi R, Tawfeeq R Ecancermedicalscience. 2023; 17:1499.

PMID: 36816786 PMC: 9937074. DOI: 10.3332/ecancer.2023.1499.

Infusion of etoposide in the CA1 disrupts hippocampal immediate early gene expression and hippocampus-dependent learning.

Boutros S, Kessler K, Unni V, Raber J Sci Rep. 2022; 12(1):12834.

PMID: 35896679 PMC: 9329441. DOI: 10.1038/s41598-022-17052-y.

References

Worsley A, Catovsky D, Goldman J, GALTON D . New combination chemotherapy for relapsed acute myeloid leukaemia. Lancet. 1984; 1(8388):1232. DOI: 10.1016/s0140-6736(84)91709-4. View

Schmitz N, Gassmann W, Rister M, Johannson W, Suttorp M, Brix F . Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood. 1988; 72(5):1567-73. View

Coonley C, Bains M, Heelan R, Dukeman M, Kelsen D . Phase II study of etoposide in the treatment of esophageal carcinoma. Cancer Treat Rep. 1983; 67(4):397-8. View

Colombo T, Broggini M, Vaghi M, Amato G, Erba E, DIncalci M . Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse. Eur J Cancer Clin Oncol. 1986; 22(2):173-9. DOI: 10.1016/0277-5379(86)90027-1. View

Perez Manga G, Madrigal Alonso P, Alburquerque Carbuccia H . Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen. Cancer Chemother Pharmacol. 1982; 7(2-3):231-3. DOI: 10.1007/BF00254557. View

Jackson Jr D, Case L, Zekan P, Powell B, CALDWELL R, Bearden J . Improvement of long-term survival in extensive small-cell lung cancer. J Clin Oncol. 1988; 6(7):1161-9. DOI: 10.1200/JCO.1988.6.7.1161. View

Tirelli U, DIncalci M, Canetta R, Tumolo S, Franchin G, Veronesi A . Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol. 1984; 2(5):432-7. DOI: 10.1200/JCO.1984.2.5.432. View

Thant M, Hawley R, Smith M, Cohen M, Minna J, Bunn P . Possible enhancement of vincristine neuropathy by VP-16. Cancer. 1982; 49(5):859-64. DOI: 10.1002/1097-0142(19820301)49:5<859::aid-cncr2820490506>3.0.co;2-9. View

Walther P, Williams S, Troner M, Greco F, Birch R, Einhorn L . Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience. Cancer Treat Rep. 1986; 70(11):1337-8. View

10.

McIllmurray M, Bibby R, Taylor B, Ormerod L, EDGE J, Wolstenholme R . Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer. Thorax. 1989; 44(3):215-9. PMC: 461757. DOI: 10.1136/thx.44.3.215. View

11.

Veronesi A, Magri M, Tirelli U, Carbone A, Mazza F, Franceschi S . Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study. Am J Clin Oncol. 1988; 11(5):566-71. DOI: 10.1097/00000421-198810000-00012. View

12.

Finn G, Bozek T, Souhami R, Slevin M, Thomas D . High-dose etoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep. 1985; 69(6):603-5. View

13.

Perry M, MOERTEL C, SCHUTT A, Reitemeier R, Hahn R . Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. Cancer Treat Rep. 1976; 60(9):1247-50. View

14.

Drings P, Abel U, Bulzebruck H, Stiefel P, Kleckow M, Manke H . Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. Cancer Chemother Pharmacol. 1986; 18 Suppl 2:S34-9. DOI: 10.1007/BF00647449. View

15.

HOLSTI P, HOLSTI L, Pyrhonen S, Mattson K . A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol. 1989; 25(7):1039-43. DOI: 10.1016/0277-5379(89)90385-4. View

16.

Perry M, EATON W, Propert K, Ware J, Zimmer B, Chahinian A . Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 1987; 316(15):912-8. DOI: 10.1056/NEJM198704093161504. View

17.

Gouyette A, Deniel A, Pico J, Droz J, Baume D, Ostronoff M . Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies. Eur J Cancer Clin Oncol. 1987; 23(11):1627-32. DOI: 10.1016/0277-5379(87)90441-x. View

18.

. Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours. Br Med J. 1973; 3(5873):199-202. PMC: 1586276. View

19.

Aisner J, Whitacre M, VanEcho D, Wesley M, Wiernik P . Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer. Cancer Chemother Pharmacol. 1982; 7(2-3):187-93. DOI: 10.1007/BF00254546. View

20.

Leff R, Thompson J, Daly M, Johnson D, Harden E, Mercier R . Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer. 1988; 62(1):32-5. DOI: 10.1002/1097-0142(19880701)62:1<32::aid-cncr2820620108>3.0.co;2-x. View